427
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Improvement of bone microarchitecture in methylprednisolone induced rat model of osteoporosis by using thiolated chitosan-based risedronate mucoadhesive film

ORCID Icon, , , , &
Pages 1845-1856 | Received 17 May 2018, Accepted 04 Jul 2018, Published online: 05 Sep 2018

References

  • Khajuria DK, Razdan R, Mahapatra DR. Development, in vitro and in vivo characterization of zoledronic acid functionalized hydroxyapatite nanoparticle based formulation for treatment of osteoporosis in animal model. Eur J Pharm Sci. 2015;66:173–183.
  • Sahana H, Khajuria DK, Razdan R. Improvement in bone properties by using risedronate adsorbed hydroxyapatite novel nanoparticle based formulation in a rat model of osteoporosis. J Biomed Nanotechnol. 2013;9:193–201.
  • Khajuria DK, Razdan R, Mahapatra DR. Drugs for the management of osteoporosis: a review. Rev Bras Rheumatol. 2011;51:365–371.
  • Rogers MJ, Crockett JC, Coxon FP. Biochemical and molecular mechanisms of action of bisphosphonates. Bone. 2011;49:34–41.
  • Roelofs AJ, Thompson K, Gordon S, et al. Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res. 2006;12:6222s–6230s.
  • Eastell R, Boonen S, Cosman F, et al. Relationship between pretreatment rate of bone loss and bone density response to once-yearly ZOL: HORIZON-PFT extension study. J Bone Miner Res. 2015;30:570–574.
  • Coxon FP, Helfrich MH, Van’t Hof R, et al. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res. 2000;15:1467–1476.
  • Millard PS, Rosen CJ, Johnson KH. Osteoporotic vertebral fractures in postmenopausal women. Am Fam Phys. 1997;55:1315–1322.
  • Paggiosi MA, Peel N, McCloskey E, et al. Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study. Osteoporos Int. 2014;25:2729–2741.
  • Mitchell DY, Eusebio RA, Sacco-Gibson NA, et al. Dose-proportional pharmacokinetics of risedronate on single-dose oral administration to healthy volunteers. J Clin Pharmacol. 2000;40:258–265.
  • Morales JO, McConville JT. Manufacture and characterization of mucoadhesive buccal films. Eur J Pharm Biopharm. 2011;77:187–199.
  • Squier CA, Wertz PW. Permeability and the pathophysiology of oral mucosa. Adv Drug Deliv Rev. 1993;12:13–24.
  • Kast CE, Frick W, Losert U, et al. Chitosan-thioglycolic acid conjugate: a new scaffold material for tissue engineering? Int J Pharm. 2003;256:183–189.
  • Britto DD, Campana-Filho SP, Assis OBGD. Mechanical properties of N,N,N -trimethylchitosan chloride films. Polim Cien Technol. 2005;15:142.
  • Mukherjee D, Bharath S. Design and characterization of double layered mucoadhesive system containing bisphosphonate derivative. ISRN Pharm. 2013;2013:1.
  • Shivanand K, Raju S, Nizamuddin S. In vivo bioavailability studies of sumatriptan succinate buccal tablets. J Facult Pharm Tehran Univ Med Sci. 2011;19:224–230.
  • Ikeuchi-Takahashi Y, Sasatsu M, Onishi H. Evaluation of matrix type mucoadhesive tablets containing indomethacin for buccal application. Int J Pharm. 2013;453:454–461.
  • Liao SK, Hung CC, Lin MF. A kinetic study of thermal degradations of chitosan/polycaprolactum blends. Macromol Res. 2004;12:466.
  • Shidhaye SS, Saindane NS, Sutar S, et al. Mucoadhesive bilayered patches for administration of sumatriptan succinate. AAPS PharmSciTech. 2008;9:909–916.
  • Nafee NA, Boraie MA, Ismail FA, et al. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharm. 2003;53:199–212.
  • Bassi P, Kaur G. Polymeric films as a promising carrier for bioadhesive drug delivery: development, characterization and optimization. Saudi Pharm J. 2017;25:32–43.
  • El-Gendy NA, Abdelbary GA, El-Komy MH, et al. Design and evaluation of a bioadhesive patch for topical delivery of gentamicin sulphate. Curr Drug Deliv. 2009;6:50–57.
  • Sanz R, Clares B, Mallandrich M, et al. Development of a mucoadhesive delivery system for control release of doxepin with application in vaginal pain relief associated with gynecological surgery. Int J Pharm. 2018;535:393–401.
  • Belgamwar V, Shah V, Surana SJ. Formulation and evaluation of oral mucoadhesive multiparticulate system containing metoprolol tartarate: an in vitro-ex vivo characterization. Curr Drug Deliv. 2009;6:113–121.
  • Bayrak Z, Tas C, Tasdemir U, et al. Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2011;78:499–505.
  • Taha EA, Youssef NF. Spectrophotometric determination of some drugs for osteoporosis. Chem Pharm Bull. 2003;51:1444–1447.
  • Salman S, Kumbasar S, Hacimuftuoglu A, et al. The effect of metyrosine/prednisolone combination to oophorectomy-induced osteoporosis. Iran J Reprod Med. 2012;10:363–372.
  • Bitto A, Burnett BP, Polito F, et al. Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol. Br J Pharmacol. 2008;155:896–905.
  • Duranova H, Martiniakova M, Omelka R, et al. Changes in compact bone microstructure of rats subchronically exposed to cadmium. Acta Vet Scand. 2014;56:64.
  • Khajuria DK, Disha C, Razdan R, et al. Prophylactic effects of propranolol versus the standard therapy on a new model of disuse osteoporosis in rats. Sci Pharm. 2014;82:357–374.
  • Donmez BO, Ozdemir S, Sarikanat M, et al. Effect of angiotensin II type 1 receptor blocker on osteoporotic rat femurs. Pharmacol Rep. 2012;64:878–888.
  • Enrione J, Osorio F, López D, et al. Characterization of a gelatin/chitosan/hyaluronan scaffold- polymer. Electron J Biotechnol. 2010;13:0–11.
  • Huang W, Wang Y, Ren L, et al. A novel PHBV/HA microsphere releasing system loaded with alendronate. Mater Sci Eng C. 2009;29:2221.
  • Yehia SA, El-Gazayerly ON, Basalious EB. Fluconazole mucoadhesive buccal films: in vitro/in vivo performance. Curr Drug Deliv. 2009;6:17–27.
  • Tanodekaew S, Prasitsilp M, Swasdison S, et al. Preparation of acrylic grafted chitin for wound dressing application. Biomaterials. 2004;25:1453–1460.
  • Rotta J, Minatti E, Barreto PLM. Determination of structural and mechanical properties, diffractometry, and thermal analysis of chitosan and hydroxypropylmethylcellulose (HPMC) films plasticized with sorbitol. Ciênc Tecnol Aliment. 2011;31:406–450.
  • Munasur AP, Pillay V, Chetty DJ, et al. Statistical optimisation of the mucoadhesivity and characterisation of multipolymeric propranolol matrices for buccal therapy. Int J Pharm. 2006;323:43–51.
  • Şenel S, İkinci G, Kaş S, et al. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int J Pharm. 2000;193:197–203.
  • Trastullo R, Abruzzo A, Saladini B, et al. Design and evaluation of buccal films as paediatric dosage form for transmucosal delivery of ondansetron. Eur J Pharm Biopharm. 2016;105:115–121.
  • Bigucci F, Abruzzo A, Saladini B, et al. Development and characterization of chitosan/hyaluronan film for transdermal delivery of thiocolchicoside. Carbohydr Polym. 2015;130:32–40.
  • Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev. 2005;57:1666–1691.
  • Bertram U, Bodmeier R. In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form. Eur J Pharm Sci. 2006;27:62–71.
  • Kashani IR, Golipoor Z, Akbari M, et al. Schwann-like cell differentiation from rat bone marrow stem cells. Arch Med Sci. 2011;7:45–52.
  • King CS, Weir EC, Gundberg CW, et al. Effects of continuous glucocorticoid infusion on bone metabolism in the rat. Calcif Tissue Int. 1996;59:184–191.
  • Turner RT, Hannon KS, Greene VS, et al. Prednisone inhibits formation of cortical bone in sham-operated and ovariectomized female rats. Calcif Tissue Int. 1995;56:311–315.
  • Reginster JY. Prevention of postmenopausal osteoporosis with pharmacological therapy: practice and possibilities. J Intern Med. 2004;255:615–628.
  • Weinstein RS, Manolagas SC. Apoptosis and osteoporosis. Am J Med. 2000;108:153–164.
  • Kalleny NK. Histological and Morphometric studies on the effect of alpha-lipoic acid on postovriectomy osteoporosis induced in adult female albino rats. Egypt J Histol. 2011;34:117–139.
  • Martiniakova M, Grosskopf B, Mokosova Z, et al. Histological analysis of compact bone tissue in adult laboratory rats. Slovak J Anim Sci. 2009;42:04.
  • Jeon OC, Seo DH, Kim HS, et al. Oral delivery of zoledronic acid by non-covalent conjugation with lysine-deoxycholic acid: in vitro characterization and in vivo anti-osteoporotic efficacy in ovariectomized rats. Eur J Pharm Sci. 2016;82:1–10.
  • Bae J, Park JW. Preparation of an injectable depot system for long-term delivery of alendronate and evaluation of its anti-osteoporotic effect in an ovariectomized rat model. Int J Pharm. 2015;480:37–47.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.